Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
PTC and Novartis’ Huntington's data fail to convince investors
Investors wiped almost 20% off PTC’s share price amid doubts about the path to accelerated approval of the asset.
Nick Paul Taylor
May 6, 2025 7:25am
Aldeyra posts hit, miss for dry eye drug, plans FDA filing
May 6, 2025 7:05am
J&J gene therapy fails ph. 3 rare eye disease trial
May 5, 2025 11:33am
Immutep's LAG-3 agent posts 'impressive' survival data
May 5, 2025 10:37am
Immunic MS asset misses primary goal of midstage trial
Apr 30, 2025 3:05pm
Pfizer ties PD-1 drug to 32% cancer risk reduction in phase 3
Apr 28, 2025 7:25am
